Anthrax.
Wenner KA, Kenner JR.
Dermatol Clin. 2004 Jul;22(3):247-56, v. doi: 10.1016/j.det.2004.03.001.
Smallpox.
Dacko A, Hardick K, Yoshida T.
Cutis. 2003 Apr;71(4):319-22.
Systemic diseases with cutaneous manifestations.
Merchant SR, Taboada J.
Vet Clin North Am Small Anim Pract. 1995 Jul;25(4):945-59. doi: 10.1016/s0195-5616(95)50136-6.
A Case of Cutaneous Plague.
De Rozario CF.
Ind Med Gaz. 1933 Jul;68(7):396.
Cutaneous manifestations of category A bioweapons.
Aquino LL, Wu JJ.
J Am Acad Dermatol. 2011 Dec;65(6):1213.e1-1213.e15. doi: 10.1016/j.jaad.2010.08.040. Epub 2011 Jul 20.
Review of category A bioweapons with cutaneous features: Epidemiology, clinical presentation, and contemporary management strategies.
Osborne S, Kam O, Thacker S, Wescott R, Vo C, Wu JJ, Rojek NW, Norton SA.
J Am Acad Dermatol. 2025 Jul;93(1):165-175. doi: 10.1016/j.jaad.2025.01.081. Epub 2025 Feb 3.
Orf Viral Infection.
Efridi W, Jain H, Sathe NC, Ahmed K.
2023 Nov 30. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
Periorbital cellulitis due to cutaneous anthrax.
Gilliland G, Starks V, Vrcek I, Gilliland C.
Int Ophthalmol. 2015 Dec;35(6):843-5. doi: 10.1007/s10792-015-0057-7. Epub 2015 Mar 13.
On Shakespeare and cutaneous diseases.
Xu J.
Clin Dermatol. 2021 Jul-Aug;39(4):714-717. doi: 10.1016/j.clindermatol.2021.05.018. Epub 2021 May 19.
Dual route vaccination for plague with emergency use applications.
Moore BD, New RRC, Butcher W, Mahood R, Steward J, Bayliss M, MacLeod C, Bogus M, Williamson ED.
Vaccine. 2018 Aug 16;36(34):5210-5217. doi: 10.1016/j.vaccine.2018.06.039. Epub 2018 Jul 14.
